TJX
62
-2
HRL
35
-3
ADP
65
-3
CA
22
-3
HSY
31
-6
CB
57
2
ED
45
3
PEP
39
-9
PG
50
2
C
62
4
REGN
38
-2
AA
56
15
BBY
52
6
DE
42
3
FAST
57
-3
CINF
53
3
EOG
56
-2
HST
39
-3
CHD
54
4
FMC
23
-3
TJX
62
-2
HRL
35
-3
ADP
65
-3
CA
22
-3
HSY
31
-6
CB
57
2
ED
45
3
PEP
39
-9
PG
50
2
C
62
4
REGN
38
-2
AA
56
15
BBY
52
6
DE
42
3
FAST
57
-3
CINF
53
3
EOG
56
-2
HST
39
-3
CHD
54
4
FMC
23
-3
Financhill
Back

Castle Biosciences Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
23

CSTL
Castle Biosciences

Last Price:
28.07
Seasonality Move:
29.89%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
23
Castle Biosciences (CSTL) is a Sell

Is Castle Biosciences a Buy, Sell or Hold?

  • The current Castle Biosciences [CSTL] share price is $28.10. The Score for CSTL is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CSTL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CSTL Stock Price Chart

What is Castle Biosciences's stock price today?

  • The Castle Biosciences share price today is $28.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CSTL is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CSTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 35.44 Sell
Chaikin Money Flow: -625956 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.18 - 33.98) Sell
Bollinger Bands (100): (22.5 - 32.28) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CSTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.07 Sell
20-day SMA: 32.45 Sell
50-day SMA: 31.06 Sell
200-day SMA: 24.83 Buy
8-day EMA: 31.42 Sell
20-day EMA: 31.94 Sell
50-day EMA: 30.78 Sell
200-day EMA: 25.94 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Castle Biosciences Earnings Growth & CSTL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.89 per share, and a decrease next year of $2.28 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Castle Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):